3'-Dehydroxypurpurogallin-4-carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, SAR Analysis, and Structural Characterization of Protein Complex.

Inhibitors Structure-activity relationships, influenza synthesis, X-ray structure

Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
14 Oct 2024
Historique:
revised: 07 10 2024
received: 25 07 2024
accepted: 07 10 2024
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

The influenza RNA-dependent RNA polymerase harbours an endonuclease subunit characterized by a catalytic site housing two divalent metal ions. By effectively chelating both Mg2+ and Mn2+ ions, a low-molecular-weight inhibitor with a metal-binding pharmacophore can halt endonuclease activity. Herein, two 3'-dehydroxypurpurogallin-4-carboxamide series, namely twelve C-4' unsubstituted and twelve C-4' phenyl substituted congeners were designed and prepared to be tested as inhibitors of the metal-dependent viral enzyme. These inhibitors were accessed through the chemoenzymatic reaction of gallic acid with either pyrocatechol or phenylpyrocatechol moderated by laccase, followed by amidation. Experimental IC50 values were determined using AlphaScreen technology, with the most potent inhibitors exhibiting IC50 values around 0.35 μM. Using X-ray crystallography, we analyzed structure of the endonuclease in complex with one potent 3'-dehydroxypurpurogallin-carboxamide at 2.0 Å resolution, revealing the coordination of the compound's triad of oxygen atoms with the two metal ions in the influenza A endonuclease active site.

Identifiants

pubmed: 39400442
doi: 10.1002/cmdc.202400577
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400577

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Ales Machara (A)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Drug discovery group, Flemingovo n. 2, 160 00, Prague, CZECHIA.

Michal Kral (M)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Proteases of Human Pathogens, CZECHIA.

Tomáš Kotačka (T)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Proteases of Human Pathogens, CZECHIA.

Robert Reiberger (R)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Drug discovery group, CZECHIA.

Gabriela Panýrková (G)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Drug discovery group, CZECHIA.

Kateřina Radilová (K)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Proteases of Human Pathogens, CZECHIA.

Zuzana Osifová (Z)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, NMR department, CZECHIA.

Miroslav Flieger (M)

Institute of Microbiology Czech Academy of Sciences, Laboratory of fungal genetics and metabolism, CZECHIA.

Jan Konvalinka (J)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Proteases of Human Pathogens, CZECHIA.

Pavel Majer (P)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Drug discovery group, CZECHIA.

Milan Kožíšek (M)

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Proteases of Human Pathogens, CZECHIA.

Classifications MeSH